Alcon Inc (CHIX:ALCz)
CHF 76.46 0.44 (0.58%) Market Cap: 37.82 Bil Enterprise Value: 41.16 Bil PE Ratio: 37.50 PB Ratio: 2.02 GF Score: 73/100

Alcon AG at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 12:00PM GMT
David Ryan Lewis
Morgan Stanley, Research Division - MD

So thanks for joining us here. My name is David Lewis, medical advisor analyst here at Morgan Stanley. It's my pleasure to have this year, Alcon, and this is the first time Alcon sort of in this iteration has been in front of the Morgan Stanley conference. So we're -- obviously a pleasure to have them. We'll talk about that a little bit. But we have 2 members of management here from Alcon, actually 3 members here actually on stage. We have CEO, Dave Endicott; CFO, Tim Stonesifer; and Karen King as many of you obviously know.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

David, I want to start actually with kind of a strategic question. This came up in our morning session yesterday about the recent medtech spins. We talk about this a lot. Medtech spins "always work." It's a bit of lore out there. One of the things we've talked about is that medical device spins, medical -- besides pharma, never mix, that this is not a very good marriage. And we think Alcon Novartis

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot